Former EU food safety commissioner: Europe can’t afford to ignore the crop gene editing revolution

eugeneedit
Credit: Beyond GM

Debate on new breeding techniques is intense. Sometimes dubbed by their opponents as the “new GMOs” who raise concerns over their safety or simply reject their use in European agriculture for various reasons including ethical issues, other stakeholders nevertheless point out the advantages and benefits offered by these techniques.

A legal input took place last year, when a ruling of the Court of Justice of the EU in July 2018 stated that current legislation on the deliberate release of GMOs applies to organisms obtained by new mutagenesis techniques.

It is now a well-known fact that I have been defending a strong position on this debate in recent months. Speaking at a Citizens’ Dialogue last autumn in Italy, I made it clear that we need to invest money, time and resources in new agricultural technologies.

[Editor’s note: Vytenis Andriukaitis is the EU’s former Health & Food Safety commissioner.]

Europe simply cannot afford to give up and stay on the side while our main competitors will not! Unsurprisingly, some of the biggest producers of GM products (the United States, Canada, Brazil, Argentina) already acknowledge the role that these new techniques could play in addressing challenges in agricultural production.

Read full, original article: The EU Must Remain a Key Actor in the Area of Seeds and New Technologies in Plants

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
ChatGPT-Image-Jun-24-2026-11_36_47-AM
Why the human genome is less a script than a puzzle
Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
Screenshot 2026-06-25 at 10.55
Leading OB-GYN group challenges RFK, Jr. gutting of maternal vaccine schedule
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
Screenshot-2026-06-24-at-2.57.41-PM
Viewpoint: Trump’s Reflecting Pool algae fiasco points to a bigger culprit: Climate change
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
Screenshot-2026-06-24-at-2.40.46-PM
Hegseth reversal: As Air Force flu outbreak continues to surge, military reinstitutes mandatory vaccines for recruits

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.